Intracranial delivery of synthetic mRNA to suppress glioblastoma
Authors:
Open Access
- 14 December 2021
- journal article
- research article
- Published by Elsevier in Molecular Therapy-Oncolytics
- Vol. 24, 160-170
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 34 references indexed in Scilit:
- Clinical perspectives of TRAIL: insights into central nervous system disordersCellular and Molecular Life Sciences, 2016
- TRAIL on trial: preclinical advances in cancer therapyTrends in Molecular Medicine, 2013
- Systemic Delivery of Modified mRNA Encoding Herpes Simplex Virus 1 Thymidine Kinase for Targeted Cancer Gene TherapyMolecular Therapy, 2013
- Antitumor Vaccination with Synthetic mRNA: Strategies for In Vitro and In Vivo Preclinical Studies2012
- Increased Erythropoiesis in Mice Injected With Submicrogram Quantities of Pseudouridine-containing mRNA Encoding ErythropoietinMolecular Therapy, 2012
- Intradermal Vaccinations With RNA Coding for TAA Generate CD8+ and CD4+ Immune Responses and Induce Clinical Benefit in Vaccinated PatientsMolecular Therapy, 2011
- Endogenous Bak inhibitors Mcl-1 and Bcl-xL: differential impact on TRAIL resistance in Bax-deficient carcinomaJournal of Cell Biology, 2010
- TRAIL as a target in anti-cancer therapyCancer Letters, 2009
- Extracellular barriers in respiratory gene therapyAdvanced Drug Delivery Reviews, 2009
- The clinical trail of TRAILEuropean Journal of Cancer, 2006